“2015-2019 New Frontiers in Point-of-Care/POC Hematology and Flow Cytometry Testing: Business Challenges, Emerging Technologies, Competitive Landscape” is VPGMarketResearch’s new report, which provides comprehensive analysis of the POC hematology and flow cytometry markets, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. Rationale The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation - Review of POC hematology and flow cytometry market segments, including their dynamics, trends, structure, size, growth and major suppliers. - Five-year test volume and reagent sales forecasts for hematology and flow cytometry procedures by market   segment: - Physician Offices/Group Practices     - Emergency Rooms        - Operating/Recovery Suites       - ICUs/CCUs  - Cancer Clinics         - Ambulatory Care Centers         - Surgery Centers  - Nursing Homes - Birth Centers Sales and Market Share Analysis - Sales and market shares of major reagent and instrument suppliers. Routine and Special Hematology Tests CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual), Hemoglobin (Automated, Manual),... Research Beam Model: Research Beam Product ID: 322015 0 USD New
2015-2019 New Frontiers in the Point-of-Care/POC Hematology and Flow Cytometry Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape
 
 

2015-2019 New Frontiers in the Point-of-Care/POC Hematology and Flow Cytometry Testing Market: Business Challenges, Emerging Technologies, Competitive Landscape

  • Category : Diagnostic and Biotech
  • Published On : August   2015
  • Pages : 279
  • Publisher : VPGMarketResearch.com
 
 
 

2015-2019 New Frontiers in Point-of-Care/POC Hematology and Flow Cytometry Testing: Business Challenges, Emerging Technologies, Competitive Landscape” is VPGMarketResearch’s new report, which provides comprehensive analysis of the POC hematology and flow cytometry markets, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.


Rationale


The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.


Market Segmentation


- Review of POC hematology and flow cytometry market segments, including their dynamics, trends, structure, size, growth and major suppliers.


- Five-year test volume and reagent sales forecasts for hematology and flow cytometry procedures by market

  segment:



- Physician Offices/Group Practices    

- Emergency Rooms       

- Operating/Recovery Suites      

- ICUs/CCUs 

- Cancer Clinics        

- Ambulatory Care Centers        

- Surgery Centers 

- Nursing Homes

- Birth Centers



Sales and Market Share Analysis


- Sales and market shares of major reagent and instrument suppliers.


Routine and Special Hematology Tests


CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual),

Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual),

Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils and others.


Flow Cytometry Tests


Cell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/RNA Analysis, Cell Culturing.


Technology Review


- Emerging technologies and their applications for POC testing.


- Comprehensive listings of companies developing or marketing POC diagnostic technologies

  and products, by test.


Strategic Recommendations


- Specific opportunities for new POC instruments and reagent systems with potentially

  significant market appeal during the next five years.


- Design criteria for POC testing products.


- Alternative business expansion strategies.


- Potential market entry barriers and risks.


Competitive Assessments


- Assessments of major suppliers and emerging market entrants, including their sales, product

  portfolios, marketing tactics, joint ventures, and new products in R&D.


- The companies analyzed in the report include:


   - Abbott

   - Agilent Technologies

   - Beckman Coulter/Danaher

   - Becton Dickinson

   - Bio-Rad

   - CellaVision

   - Horiba

   - Iris Diagnostics/Danaher

   - Nihon Kohden

   - Ortho-Clinical Diagnostics

   - Roche

   - Siemens

   - Sysmex

  

Methodology


This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.


Contains 279  pages and 58 tables

../toc/TOCLOT%20NewFrontiersinPointofCarePOCHFCTesting.pdf
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT